Semagacestat is an inhibitor of γ-secretase. It inhibits Aβ42, Aβ38, Aβ40 and the Notch signaling with IC50 of 10 nM, 12 nM, 12.1 nM and 14.1 nM.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Semagacestat is a γ-secretase inhibitor with efficacy in multiple cellular and animal models, with IC50 values of 10.9nM, 12.1nM, 12nM, 14.1nM for secretion of Aβ42, Aβ40, Aβ38 and Notch, respectively, and EC50 value of 16nM forβ-CTF production. Exposure to Semagacestat at concentration ranging in 3.2, 16, 80, 2000, and 10,000 nM for 24 h led a concentration-dependent increase of β-CTF and α-CTF in H4 cells stably overexpressing human wild-type APP. It is regarded as a candidate drug for a causal therapy against Alzheimer's disease and showed blood-brain barrier permeability. Oral administration of semagacestat at dose of 1mg for 8 days significantly ameliorated spatial working memory deficits (shown by Y-maze) in Tg2576 mice (5.5-monthold) on day 1, but not on day 8. Both reduction of hippocampal Aβ42/Aβ40 by 22–23% and elevation of β-CTF by 162% could be observed in Tg2576 mice after dose of 10mg. A subcutaneous injection of semagacestat at dose of 5 mg/kg immediately after traumatic brain injury and once daily for 3 consecutive days post-traumatic brain injury attenuated neurotrauma and neurogenic acute lung injury in rats due to reducing the accumulation of hypertrophic microglia in the vicinity of the lesion. |
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
African green monkey CV1 cells | Function assay | Inhibition of gamma-secretase expressed in african green monkey CV1 cells coexpressing Gal4 DNA-binding/transactivation domain assessed as inhibition of notch processing by luciferase reporter assay, IC50=0.31623 μM | 20056541 | ||
CHO cells | Function assay | Inhibition of gamma-secretase in CHO cells assessed expressing APPSw assessed as inhibition of amyloid beta(1 to x) secretion after overnight incubation by ELISA, ED50=0.015 μM | 23713656 | ||
human SH-SY5Y cells | Function assay | Inhibition of gamma secretase-mediated amyloid beta (1 to 40) production in human SH-SY5Y cells, IC50=0.038 μM | 19694467 |
Dose | Mice: 3 mg/kg - 30 mg/kg[1] (p.o.); 1000 mg/kg[4] (s.c. BID or p.o.) Guinea pig: 0.2 mg/kg- 60 mg/kg[5] (p.o.) |
Administration | p.o., s.c. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.77mL 0.55mL 0.28mL |
13.83mL 2.77mL 1.38mL |
27.67mL 5.53mL 2.77mL |
CAS号 | 425386-60-3 |
分子式 | C19H27N3O4 |
分子量 | 361.435 |
别名 | LY450139 |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry,2-8°C |
溶解方案 |
DMSO: 105 mg/mL(290.51 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
动物实验配方 |
0.5% methylcellulose+water 30 mg/mL suspension |